Since launching in 2015, the Hawthorne Effect solution has been used across more than 50 clinical trials, of which 99% of visits and assessments were completed within the trial window, even for the most complex of visit requirements. Hawthorne Effect is actively engaged with more than 260 clinical sites and also runs trials as a single virtual site.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
06/09/21 | $20,000,000 | Series A |
Northpond Ventures P5 Health Ventures SignalFire | undisclosed |